Population biological principles of drug-resistance evolution in infectious diseases.
about
Application of PK/PD Modeling in Veterinary Field: Dose Optimization and Drug Resistance PredictionDetecting rare gene transfer events in bacterial populationsThe potential impact of coinfection on antimicrobial chemotherapy and drug resistanceOn being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the communityOptimizing treatment regimes to hinder antiviral resistance in influenza across time scalesGenetic and genomic architecture of the evolution of resistance to antifungal drug combinationsHsp90 inhibitors exhibit resistance-free antiviral activity against respiratory syncytial virusAggressive chemotherapy and the selection of drug resistant pathogensResource competition may lead to effective treatment of antibiotic resistant infectionsRapid response to selection, competitive release and increased transmission potential of artesunate-selected Plasmodium chabaudi malaria parasitesA population model evaluating the consequences of the evolution of double-resistance and tradeoffs on the benefits of two-drug antibiotic treatmentsPersistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgroundsRational Design and Adaptive Management of Combination Therapies for Hepatitis C Virus InfectionExisting Infection Facilitates Establishment and Density of Malaria Parasites in Their Mosquito VectorConflicting Selection Pressures Will Constrain Viral Escape from Interfering Particles: Principles for Designing Resistance-Proof AntiviralsDoes High-Dose Antimicrobial Chemotherapy Prevent the Evolution of Resistance?Cancer in light of experimental evolutionThe global spread of drug-resistant influenza.From in vitro to in vivo Models of Bacterial Biofilm-Related Infections.Classic reaction kinetics can explain complex patterns of antibiotic action.Timing of pathogen adaptation to a multicomponent treatment.The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.Prevalence, aetiology and antibiotic sensitivity profile of asymptomatic bacteriuria isolates from pregnant women in selected antenatal clinic from Nairobi, KenyaAn overview of antimicrobial resistance and its public health significance.Exploring the collaboration between antibiotics and the immune response in the treatment of acute, self-limiting infectionsAntiviral drug resistance as an adaptive processComparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis.Modelling the evolutionary dynamics of viruses within their hosts: a case study using high-throughput sequencing.Phages limit the evolution of bacterial antibiotic resistance in experimental microcosms.Clonal expansion and emergence of environmental multiple-triazole-resistant Aspergillus fumigatus strains carrying the TR₃₄/L98H mutations in the cyp51A gene in India.Antibiotic resistance: a primer and call to actionThe value of monitoring to control evolving populationsStrain diversity, epistasis and the evolution of drug resistance in Mycobacterium tuberculosis.Limits to compensatory adaptation and the persistence of antibiotic resistance in pathogenic bacteria.The evolution of drug resistance and the curious orthodoxy of aggressive chemotherapyUnderstanding genetic variation in in vivo tolerance to artesunate: implications for treatment efficacy and resistance monitoringA role for systems epidemiology in tuberculosis researchOld and new selective pressures on Mycobacterium tuberculosis.Is selection relevant in the evolutionary emergence of drug resistance?The fitness of drug-resistant malaria parasites in a rodent model: multiplicity of infection
P2860
Q26753831-92736923-4136-40E1-B623-59A94816578CQ27686958-B4B73458-C6E7-4355-B755-8DBC6CF37301Q28081282-7A95111B-ECCF-4F2A-8CD6-6AB38A5C9BD1Q28477757-2766C311-C8B7-471D-8BB7-34BCC1C75E53Q28485862-0D3BD352-3C6E-4953-A768-A4B58555C89CQ28486002-64FF7CC1-F9D0-4874-8170-462A66200EC2Q28486995-9855D02B-6A0C-496C-9AB7-DE0B84CD34E4Q28533328-705043A1-4617-4083-97CC-923C0F568133Q28537662-D61B6D5D-E4F1-4CB5-A0B9-28B21B2E2CFBQ28538245-4E2519F4-C6AD-4D99-A46B-B11A74877CFAQ28539364-E228FAF9-D2D7-4A5D-8E12-D406F2E88A25Q28544845-07514FC9-4A08-4D3F-84A5-E2370CA96450Q28545971-8CF61594-90EE-4CE0-BE77-16C70072B3D2Q28546601-29704AA2-E413-4AF5-9ACE-FEACD18734E6Q28551872-EE7D1A50-754F-4677-818B-6084BDCBADCAQ28552950-C909B20D-F863-4732-B71C-3CE3BE6FE078Q28727500-1C4B4811-E078-47DE-AB4F-17EB4E70E6D1Q30406360-69D9222A-848F-4027-92AE-E3B6E3745B36Q30424697-A46A75AE-464E-44F6-B1BF-E7634F54D7E8Q30662980-BAE20D18-A130-4DF0-8ED3-A33264CD5156Q31131957-E5E85291-C0B0-492A-A62C-66D7EA7DD45BQ33576860-076548BA-2ABB-4806-85B0-66517F813E0FQ33583623-490FDCC8-F6BA-41FD-94BF-5BFF082F5211Q33761875-8B51156D-2E20-4CC3-B3B8-CFD4BE1D95AFQ33767602-DA1FD8BE-BFBD-4D66-B254-D6287DC334C7Q33878407-9BE609E8-6725-430F-94EE-D640EAF6B00BQ34057296-989C1ECF-B8B1-420D-8DAD-FCE542A3EA3CQ34244906-58D82878-8406-4B0E-AB52-ABD1DB32AC16Q34426663-242951AA-2D82-43C8-83D7-A835A1B2D7C2Q34534761-E602F529-5AE9-424D-B695-170F4506FCA2Q34765528-42CA21A7-202A-4469-9CF1-53532CAC3B9BQ35038019-6B71EB85-FD45-4CFD-893C-84D2BEC60C0FQ35065085-F2BF12FD-BFEB-4DB2-8EB3-A254AC4C49B3Q35069590-75AFEAE9-3FDB-4F7F-9685-19E5EF58F9C2Q35092451-534FAB8D-D6BF-48E6-8E27-BFBFBCA444AAQ35236718-63DDB380-70F3-4A98-AB5A-68E1873A3BE6Q35250742-245B8147-7250-4653-A2E8-02578382537FQ35659421-3385AC65-F0A3-49FE-AC5F-EADE1AC956CCQ35826386-3F0BA6A5-9866-44FC-9FD9-45795AAFE44DQ35831322-809C1B39-A24A-4236-AE1D-E0017CE9D3F2
P2860
Population biological principles of drug-resistance evolution in infectious diseases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Population biological principles of drug-resistance evolution in infectious diseases.
@en
Population biological principles of drug-resistance evolution in infectious diseases.
@nl
type
label
Population biological principles of drug-resistance evolution in infectious diseases.
@en
Population biological principles of drug-resistance evolution in infectious diseases.
@nl
prefLabel
Population biological principles of drug-resistance evolution in infectious diseases.
@en
Population biological principles of drug-resistance evolution in infectious diseases.
@nl
P50
P1476
Population biological principles of drug-resistance evolution in infectious diseases.
@en
P2093
Jan Engelstädter
Roland R Regoes
P304
P356
10.1016/S1473-3099(10)70264-4
P577
2011-03-01T00:00:00Z